PTPRC and neoplasm: CD45+CD11c+ cells, including both CD11bhi and CD11bint DC subpopulations, were electronically sorted from tumor cell suspensions to a high purity (>96%) and used to stimulate the proliferation of OVA-specific CD4+ OTII and CD8+ OTI T cells in vitro.